The influence of social capital and evidence-based orientation on psychiatrists' attitudes toward antipsychotic polypharmacy in schizophrenia.

ABSTRACT: Despite showing no superiority over monotherapy, antipsychotic polypharmacy (APP) is used in up to half of schizophrenia patients. However, no standardized instrument currently exists to systematically evaluate clinicians' attitudes toward APP and the role of social capital, underscoring the need for such a tool. This study presents the development of a scale designed to measure psychiatrists' attitudes toward APP. It further investigates factors associated with more evidence-based medicine (EBM) attitudes, including social capital, general EBM orientation, and demographics. The Knowledge and Attitude scale toward Antipsychotic Polypharmacy in Schizophrenia (KAAPS) was developed and pre-tested. The questionnaire also incorporated measures of professional social capital, the Evidence-Based

SUBMITTER: Juliette L 

PROVIDER: S-EPMC12804860 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature